Health Care, Pharmaceuticals, Biotech,
Government,
Constitutional Law,
Civil Litigation
Jan. 6, 2021
State drug price law doesn’t affect interstate commerce, judge rules
The law requires manufacturers to report price increases of 16% or more over a two-year period, and to provide a 60-day notice and an explanation for the increase to the Department of Managed Health Care and California Department of Insurance .
State drug price law doesn't affect interstate commerce, judge rules
A federal judge has upheld the legality of a 2017 California drug transparency law.
Senior U.S. District Judge Morrison C. England Jr. rejected claims from a pharmaceutical industry group that SB 17 violates the commerce clause of the U.S. Constitution by regulating...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care, Pharmaceuticals, Biotech, Government
Drug makers seek to block drug price reporting law
Feb. 12, 2020
By Malcolm Maclachlan
By Malcolm Maclachlan
Civil Litigation, Government
Amgen doesn’t have to disclose price increases to the state, judge rules
Feb. 6, 2019
By Justin Kloczko
By Justin Kloczko
Civil Litigation
Orange County jury awards $2 million in $103-million damages request
Oct. 3, 2019
By Meghann Cuniff
By Meghann Cuniff
